| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440002 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440003 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440004 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440005 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440006 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440007 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 9,5 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60440008 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439001 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439002 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439003 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439004 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439005 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439006 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439007 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVERTAS 4,6 mg/24 h | RIVASTIGMINUM | PLASTURE TRANSDERMIC | N06DA03 | W60439008 | ZENTIVA K.S. - REPUBLICA CEHA | ||||||
| EVEROLIMUS PHARMAZAC 5 mg | EVEROLIMUS | COMPR. | L01EG02 | W67293001 | PHARMAZAC S.A. - GRECIA | ||||||
| EVEROLIMUS PHARMAZAC 5 mg | EVEROLIMUS | COMPR. | L01EG02 | W67293002 | PHARMAZAC S.A. - GRECIA | ||||||
| EVEROLIMUS PHARMAZAC 5 mg | EVEROLIMUS | COMPR. | L01EG02 | W67293003 | PHARMAZAC S.A. - GRECIA | ||||||
| EVEROLIMUS PHARMAZAC 2,5 mg | EVEROLIMUS | COMPR. | L01EG02 | W67292001 | PHARMAZAC S.A. - GRECIA | ||||||
| EVEROLIMUS PHARMAZAC 2,5 mg | EVEROLIMUS | COMPR. | L01EG02 | W67292002 | PHARMAZAC S.A. - GRECIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman